LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

Inicio・Lista de Acciones・Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc

Cerrado

2.52 5.88

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

2.29

Máximo

2.53

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 meses	+89.87 upside

Dividendos
By Dow Jones
Próximas Ganancias	7 nov 2024

Amylyx Pharmaceuticals Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

9 sept 2024, 23:02 UTC

Principales Noticias

Ganancias

U.S. Dividends Grew 9% in the Second Quarter. Meta and Alphabet Gave a Boost. -- Barrons.com

9 sept 2024, 23:00 UTC

Adquisiciones, fusiones, absorciones

U.S. Presses Its Antitrust Cases Against Google, Tapestry -- Barrons.com

9 sept 2024, 22:27 UTC

Charlas de Mercado

U.S. Solar-Panel Manufacturing Capacity Rises Four Fold in Two Years -- Market Talk

9 sept 2024, 22:19 UTC

Principales Noticias

Ganancias

Goldman CEO Solomon Expects Trading Revenue Drop in Third Quarter -- Barrons.com

9 sept 2024, 21:01 UTC

Principales Noticias

Incoming Starbucks CEO's Tall Order: Calming Anxious Employees -- Update

9 sept 2024, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

9 sept 2024, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 sept 2024, 20:48 UTC

Adquisiciones, fusiones, absorciones

IBM to Acquire Accelalpha, an Oracle Consultancy

9 sept 2024, 20:44 UTC

Principales Noticias

Ganancias

Oracle 1Q Profit, Rev Rise Amid Additional AI Contract Wins

9 sept 2024, 20:40 UTC

Principales Noticias

Dow, S&P 500 Rise More Than 1% to Start the Week -- WSJ

9 sept 2024, 20:32 UTC

Adquisiciones, fusiones, absorciones

IBM to Acquire Accelalpha, Leading Oracle Consultancy >IBM

9 sept 2024, 20:32 UTC

Adquisiciones, fusiones, absorciones

IBM: Accelalpha Will Join IBM Consulting >IBM

9 sept 2024, 20:32 UTC

Adquisiciones, fusiones, absorciones

IBM: Acquisition Expands IBM's Oracle Consulting Expertise in Supply Chain and Logistics, Finance, Enterprise Performance Management

9 sept 2024, 20:32 UTC

Adquisiciones, fusiones, absorciones

IBM Didn't Disclose Financial Details of Accelalpha Acquisition >IBM

9 sept 2024, 20:31 UTC

Principales Noticias

DirecTV Subscribers Might Miss 'Monday Night Football' as Fight With Disney Drags On -- WSJ

9 sept 2024, 20:31 UTC

Principales Noticias

Dow, S&P 500 Rise More Than 1% to Start the Week -- WSJ

9 sept 2024, 20:30 UTC

Principales Noticias

Norfolk Southern CEO Expected to Depart Amid Board Probe -- 2nd Update

9 sept 2024, 20:30 UTC

Adquisiciones, fusiones, absorciones

IBM to Acquire Accelalpha, Leading Oracle Consultancy

9 sept 2024, 20:30 UTC

Adquisiciones, fusiones, absorciones

IBM To Acquire Accelalpha, Leading Oracle Consultancy >IBM

9 sept 2024, 20:22 UTC

Ganancias

Oracle Stock Jumps On Earnings Beat, Amazon Partnership -- IBD

9 sept 2024, 20:17 UTC

Ganancias

Oracle Earnings Beat Estimates. The Stock Is Rising. -- Barrons.com

9 sept 2024, 20:06 UTC

Ganancias

Oracle: Strong Contract Backlog to Increase Revenue Growth Throughout FY25 >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Hardware Revenue $655M >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Rev $13.31B >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Cloud License and On-Premise License Revenue $870M >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Services Revenue $1.26B >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Cloud Services and License Support Revenue $10.52B >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Adj EPS $1.39 >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Net $2.9B >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q EPS $1.03 >ORCL

Comparación entre iguales

Cambio de precio

Amylyx Pharmaceuticals Inc Esperado

Precio Objetivo

By TipRanks

89.87% repunte

Estimación a 12 meses

Media 4.5 USD 89.87%

Máximo 8 USD

Mínimo 3 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Amylyx Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para Amylyx Pharmaceuticals Inc Dist en los últimos 3 meses.

Otras acciones del sector

LLY

Eli Lilly and Co.

908.52

↑ +0.64%

UNH

UnitedHealth Group Inc

593.89

↓-0.49%

NVO

Novo Nordisk A-S

131.93

↑ +0.67%

JNJ

Johnson and Johnson

166.62

↑ +1.37%

ABBV

AbbVie Inc

196.25

↑ +1.59%

Amylyx Pharmaceuticals Inc

Resumen

Variación precio

Recomendaciones

Dividendos

Amylyx Pharmaceuticals Inc Gráfico

Noticias Relacionadas

Comparación entre iguales

Amylyx Pharmaceuticals Inc Esperado

Precio Objetivo

Consenso

Otras acciones del sector